Thiotepa for Injection

Thiotepa for Injection
Product Description

Thiotepa for Injection USP is an alkylating agentused to treat cancer.

Strength: 15mg/vial

Approved by US-FDA.
Dossiers for EU market have been filed.

Jiangsu Hengrui Medicine Co., Ltd.

  • CN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 5000+
    Employees
Company types
Manufacturer/Innovator
Specifications
  • CAS Registry Number
    52-24-4

Jiangsu Hengrui Medicine Co., Ltd.

  • CN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 5000+
    Employees
Company types
Manufacturer/Innovator

More Products from Jiangsu Hengrui Medicine Co., Ltd. (99)

  • Docetaxel Injection

    Product Docetaxel Injection

    It is used  for treatment of locally advanced or metastatic breast cancer, head and neck cancer, gastric cancer, hormone-refractory prostate cancer and non small-cell lung cancer.

    Strength: 20mg/1ml; 80mg/4ml;160mg/8ml---US FDA and NMPA approved.
    Strength: 20mg/0.5 ml ...
  • Gabapentin Capsules

    Product Gabapentin Capsules

    Gabapentin is a medication used to treatepilepsy, neuropathic pain, hot flashes, and restless leg syndrome. In epilepsy it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic n...
  • Irinotecan HCl Injection

    Product Irinotecan HCl Injection

    The main use of this product is in colon cancer, in particular, in combination with other chemotherapy agents.

    Strength: 40mg/2ml; 100mg/5ml.

    NMPA approved.
    MA issued from US-FDA, Japanese PMDA.
  • Letrozole Tablets

    Product Letrozole Tablets

    Letrozole is an oral non-steroidal aromatase inhibitor for the treatment of hormonally-responsive breast cancer after surgery.

    Strength: 2.5mg.

    Letrozole Tablets is approved by NMPA and EU GMP (Spain and  Netherlands), and have MA issued from US-F...
  • Oxaliplatin for Injection

    Product Oxaliplatin for Injection

    Oxaliplatin is a platinum-based antineoplastic agent used in cancerchemotherapy.

    Strength: 50mg/vial.

    It is the first injection product of domestic pharmaceutical enterprises approved to get launched in the European market.
    MA issued from Spain, Netherlands CBG and UK MH...
  • Fondaparinux Injection

    Product Fondaparinux Injection

    Fondaparinux is an anticoagulant medication chemically related to low molecular weight heparins.
    Strength: 0.5ml:2.5mg; 0.4ml:0.5mg; 0.6ml:7.5mg; 0.8ml:10mg.

    It is approved by US-FDA.
  • Lopamidol Injection

    Product Lopamidol Injection

    It is a kind of contrast agent.

    Strength: 
    (300mg iodine/ml) 61% *50ml *100ml  
    (370mg iodine/ml) 76% *50ml *100ml *150ml *200ml


    It is in R&D stage.
  • Tolvaptan HCl Tablets

    Product Tolvaptan HCl Tablets

    It is used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH).

    Strength: 15mg; 30mg.

    Tolvaptan HCl Tablets have been approved by CFDA...
  • Oxaliplatin Injection

    Product Oxaliplatin Injection

    Oxaliplatin is a platinum-based antineoplastic agent used in cancerchemotherapy.

    Strength: 50mg/10ml; 100mg/20ml.


    NMPA approved; MA issued from US-FDA.

  • Capecitabine Tablets

    Product Capecitabine Tablets

    It is an orally-administered chemotherapeutic agent used in the treatment of numerous cancers. It is a prodrug that is enzymatically converted to 5-fluorouracil (5-FU) in the body.

    Strength: 150mg; 500mg

    CFDA approved.

    US-AN...
  • Carmustine for Injection (with diluent)

    Product Carmustine for Injection (with diluent)

    It is a medication used mainly for chemotherapy and sometimes for immunosuppression before organ transplantation. It is used in the treatment of several types of brain cancer (including glioma, glioblastoma multif...
  • Daptomycin for Injection

    Product Daptomycin for Injection

    Daptomycin is a lipopeptide antibiotic used in the treatment of systemic and life-threatening infections caused by Gram-positive organisms.

    Strength: 500mg/vial.


    This product has been approved by NMPA in 2016.

    It is approved by US-FDA.

Jiangsu Hengrui Medicine Co., Ltd. resources (1)